Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (E.G.F.).
Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (S.A.-G., D.K., F.X.G.-O., A.N.W., S.T., T.A.G.).
Hypertension. 2023 Aug;80(8):1614-1623. doi: 10.1161/HYPERTENSIONAHA.122.20401. Epub 2023 Feb 8.
Sub-Saharan Africa is undergoing an epidemiologic transition from infectious diseases to cardiovascular diseases. From 2014 to 2019, sociodemographic surveillance was performed in a large cohort in rural South Africa.
Disease prevalence and incidence were calculated using inverse probability weights. Poisson regression was used to identify disease predictors. The percentage of individuals with controlled (<140/90 mm Hg) versus uncontrolled hypertension was compared between 2014 and 2019.
Compared with 2014 (n=5059), study participants in 2019 (n=4176) had similar rates of obesity (mean body mass index, 27.5±10.0 versus 27.0±6.5) but higher smoking (9.1% versus 11.5%) and diabetes (11.1% versus 13.9%). There was no significant increase in hypertension prevalence (58.4% versus 59.8%; age adjusted, 64.3% versus 63.3%), and there was a significant reduction in mean systolic blood pressure (138.0 versus 128.5 mm Hg; <0.001). Among hypertensive individuals who reported medication use in 2014 and 2019 (n=796), the proportion with controlled hypertension on medication increased from 44.5% to 62.3%. Hypertension incidence was 6.2 per 100 person-years, and age was the only independent predictor. Among normotensive individuals in 2014 (n=2257), 15.2% developed hypertension by 2019, with the majority already controlled on medications by 2019.
The hypertension prevalence and incidence are plateauing in this aging cohort. There was a statistically and clinically significant decline in mean blood pressure and a substantial increase in individuals with controlled hypertension on medication. The prevalence of cardiometabolic risk factors did not decrease over time, suggesting that the blood pressure decrease is likely due to increased medication access and adherence, promoted by local health systems.
撒哈拉以南非洲正经历从传染病到心血管疾病的流行病学转变。从 2014 年到 2019 年,在南非农村地区的一个大型队列中进行了社会人口学监测。
使用逆概率权重计算疾病的患病率和发病率。使用泊松回归来确定疾病的预测因素。比较了 2014 年和 2019 年血压控制(<140/90mmHg)与未控制的高血压个体的百分比。
与 2014 年相比(n=5059),2019 年研究参与者的肥胖率相似(平均体重指数,27.5±10.0 与 27.0±6.5),但吸烟率(9.1%与 11.5%)和糖尿病率(11.1%与 13.9%)更高。高血压患病率无显著增加(58.4%与 59.8%;年龄校正后,64.3%与 63.3%),平均收缩压显著降低(138.0 与 128.5mmHg;<0.001)。在 2014 年和 2019 年报告药物使用的高血压患者中(n=796),药物治疗控制血压的比例从 44.5%增加到 62.3%。高血压发病率为 6.2/100 人年,年龄是唯一的独立预测因素。在 2014 年的血压正常的个体中(n=2257),15.2%在 2019 年发展为高血压,其中大多数在 2019 年已通过药物控制血压。
在这个老龄化队列中,高血压的患病率和发病率趋于稳定。平均血压有统计学和临床意义上的显著下降,同时服用药物控制血压的人数显著增加。随着时间的推移,心血管代谢危险因素的患病率并没有下降,这表明血压下降可能是由于当地卫生系统促进了药物获取和依从性的提高。